ARCHIVES

Program Monitors Resistance In Antimicrobial And Antifungal Therapies for Cancer Patients

This article is from The Cancer Letter archive.

Vol. 25 No. 11 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: CAM Research Center Applications Sought.

January 3, 2003

Death On Saltz Regimen Prompt Groups To Suspend Accrual On Colon Cancer Trials.

May 11, 2001

NCI-Approved Cancer Center, Cooperative Group Trials

April 27, 2007

Immune Therapy Possible For Metastatic Breast Cancer

September 24, 2004

Insurance Co. Official Says Cancer Centers, Insurers Are “Allies”

June 2, 1995

In Brief: NCI To Work More Closely With Biotherapeutics, DeVita Says; apportionment May Be Abolished

February 12, 1988